Preferred Supramolecular Organization and Dimer Interfaces of Opioid Receptors from Simulated Self-Association

PLoS Computational Biology

Volumn 11, Issue 3, 2015, Pages

  Provasi, Davide ^a   Boz, Mustafa Burak ^a   Johnston, Jennifer M ^a   Filizola, Marta ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION REACTIONS; COARSE-GRAINED MODELING; CYTOLOGY; DIMERS; MOLECULAR DYNAMICS; SUPRAMOLECULAR CHEMISTRY;

BIOLOGICAL FUNCTIONS; COARSE-GRAINED MOLECULAR DYNAMICS SIMULATIONS; DIMER INTERFACE; DYNAMICS SIMULATION; EXPERIMENTAL ASSESSMENT; OPIOID RECEPTORS; RECEPTOR COMPLEX; SELF-ASSOCIATIONS; SIGNALING UNITS; SUPRAMOLECULAR ORGANIZATIONS;

LIPID BILAYERS;

BETA 1 ADRENERGIC RECEPTOR; DELTA OPIATE RECEPTOR; DIMER; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; LIPID; OPIATE RECEPTOR; PROTEIN SUBUNIT;

ARTICLE; BAYES THEOREM; CELL MEMBRANE; CRYSTAL STRUCTURE; DIMERIZATION; LIPID BILAYER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTATIONAL ANALYSIS; OLIGOMERIZATION; BIOLOGY; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SUBUNIT; ULTRASTRUCTURE;

COMPUTATIONAL BIOLOGY; HUMANS; LIPIDS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; RECEPTORS, OPIOID;

EID: 84926360598     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004148     Document Type: Article

References (46)

1. Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, et al. G Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives. Pharmacological Reviews 2014;66: 1–22. doi: 10.1124/pr.113.007724 24218476
2. Fujita W, Gomes I, Devi LA, Revolution in GPCR Signaling: Opioid receptor heteromers as novel therapeutic targets. Br J Pharmacol. 2014;171: 4155–76. doi: 10.1111/bph.12798 24916280
3. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 2010;3: ra54.
4. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, et al. Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation. Neuron 2011;69: 120–131. doi: 10.1016/j.neuron.2010.12.001 21220103
5. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA, A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 2004;101: 5135–5139. 15044695
6. Daniels DJ, Kulkarni A, Xie Z, Bhushan RG, Portoghese PS, A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. J Med Chem 2005;48: 1713–1716. 15771416
7. Harvey JH, Long DH, England PM, Whistler JL, Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers. ACS Med Chem Lett 2012;3: 640–644. 23585918
8. Lenard NR, Daniels DJ, Portoghese PS, Roerig SC, Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Eur J Pharmacol 2007;566: 75–82. 17383633
9. Gomes I, Fujita W, Gupta A, Saldanha SA, Negri A, Pinello CE, et al. Identification of a mu-delta opioid receptor heteromer-biased agonist with antinociceptive activity. Proc Natl Acad Sci U S A 2013;110: 12072–12077. doi: 10.1073/pnas.1222044110 23818586
10. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, et al. From the Cover: A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 2005;102: 9050–9055. 15932946
11. Ansonoff MA, Portoghese PS, Pintar JE, Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands. Psychopharmacology (Berl) 2010;210: 161–168. doi: 10.1007/s00213-010-1826-7 20333506
12. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. Crystal structure of the mu-opioid receptor bound to a morphinan antagonist. Nature 2012;485: 321–326. doi: 10.1038/nature10954 22437502
13. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012;485: 327–332. doi: 10.1038/nature10939 22437504
14. Johnston JM, Filizola M, Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. PLoS One 2014;9: e90694. doi: 10.1371/journal.pone.0090694 24651466
15. Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, et al. Structure of the delta-opioid receptor bound to naltrindole. Nature 2012;485: 400–404. doi: 10.1038/nature11111 22596164
16. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, de Vries AH, The MARTINI force field: coarse grained model for biomolecular simulations. J Phys Chem B 2007;111: 7812–7824. 17569554
17. Monticelli L, Kandasamy SK, Periole X, Larson RG, Tieleman DP, Marrink SJ, The MARTINI coarse-grained force field: Extension to proteins. Journal of Chemical Theory and Computation 2008;4: 819–834.
18. Periole X, Cavalli M, Marrink SJ, Ceruso M, Combining an elastic network with a coarse-grained molecular force field: structure, dynamics and intermolecular recognition. J Chem Th Comp 2009;5: 2531–2543.
19. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K, Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature 2003;421: 127–128. 12520290
20. Periole X, Knepp AM, Sakmar TP, Marrink SJ, Huber T, Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. J Am Chem Soc 2012;134: 10959–10965. doi: 10.1021/ja303286e 22679925
21. Calebiro D, Rieken F, Wagner J, Sungkaworn T, Zabel U, Borzi A, et al. Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci U S A 2013;110: 743–748. doi: 10.1073/pnas.1205798110 23267088
22. Filizola M, Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery? Life Sci 2010;86: 590–597. doi: 10.1016/j.lfs.2009.05.004 19465029
23. Huang J, Chen S, Zhang JJ, Huang XY, Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol 2013;20: 419–425. doi: 10.1038/nsmb.2504 23435379
24. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists. Science 2010;330: 1066–71. doi: 10.1126/science.1194396 20929726
25. Jung Y, Garrahan JP, Chandler D, Dynamical exchanges in facilitated models of supercooled liquids. J Chem Phys 2005;123: 084509. 16164314
26. Javanainen M, Hammaren H, Monticelli L, Jeon JH, Miettinen MS, Martinez-Seara H, et al. Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes. Faraday Discuss 2013;161: 397–417; discussion 419–359. 23805752
27. Goose JE, Sansom MS, Reduced lateral mobility of lipids and proteins in crowded membranes. PLoS Comput Biol 2013;9: e1003033. doi: 10.1371/journal.pcbi.1003033 23592975
28. Domanski J, Marrink SJ, Schafer LV, Transmembrane helices can induce domain formation in crowded model membranes. Biochim Biophys Acta 2012;1818: 984–994. doi: 10.1016/j.bbamem.2011.08.021 21884678
29. Pronk S, Lindahl E, Kasson PM, Dynamic heterogeneity controls diffusion and viscosity near biological interfaces. Nat Commun 2014;5: 3034. doi: 10.1038/ncomms4034 24398864
30. Kramers HA, Brownian motion in a field of force and the diffusion model of chemical reactions. Physica 1940;7: 284–304.
31. Hummer G, Position-dependent diffusion coefficients and free energies from Bayesian analysis of equilibrium and replica molecular dynamics simulations. New J Phys 2005;7: 34.
32. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007;318: 1258–1265. 17962520
33. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 2008;16: 897–905. doi: 10.1016/j.str.2008.05.001 18547522
34. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 2012;337: 232–236. doi: 10.1126/science.1219218 22798613
35. Zheng H, Pearsall EA, Hurst DP, Zhang Y, Chu J, Zhou Y, et al. Palmitoylation and membrane cholesterol stabilize mu-opioid receptor homodimerization and G protein coupling. BMC Cell Biol 2012;13: 6. doi: 10.1186/1471-2121-13-6 22429589
36. Mondal S, Johnston JM, Wang H, Khelashvili G, Filizola M, Weinstein H, Membrane driven spatial organization of GPCRs. Sci Rep 2013;3: 2909. doi: 10.1038/srep02909 24105260
37. Mondal S, Khelashvili G, Shan J, Andersen OS, Weinstein H, Quantitative modeling of membrane deformations by multihelical membrane proteins: application to G-protein coupled receptors. Biophys J 2011;101: 2092–2101. doi: 10.1016/j.bpj.2011.09.037 22067146
38. Bohinc K, Kralj-Iglič V, May S, Interaction between two cylindrical inclusions in a symmetric lipid bilayer. J Chem Phys 2003;119: 7435.
39. Wang C, Bradley P, Baker D, Protein-protein docking with backbone flexibility. J Mol Biol 2007;373: 503–519. 17825317
40. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, et al. Molecular control of delta-opioid receptor signalling. Nature 2014;506: 191–196. doi: 10.1038/nature12944 24413399
41. Ballesteros JA, Weinstein H, Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Meth Neurosci 1995;25: 366–428.
42. Provasi D, Johnston JM, Filizola M, Lessons from free energy simulations of delta-opioid receptor homodimers involving the fourth transmembrane helix. Biochemistry 2010;49: 6771–6776. doi: 10.1021/bi100686t 20617813
43. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ, GROMACS: Fast, flexible, and free. J Comput Chem 2005;26: 1701–1718. 16211538
44. Lunn D, Spiegelhalter D, Thomas A, Best N, The BUGS project: Evolution, critique and future directions. Stat Med 2009;28: 3049–3067. doi: 10.1002/sim.3680 19630097
45. Metzler R, Klafter J, The random walk's guide to anomalous diffusion: a fractional dynamics approach. Phys Rep 2000;339: 1–77.
46. Jarzynski C, Nonequilibrium equality for free energy differences. Physical Review Letters 1997;78: 2690–2693.